Editorial commentary: QTdrugs: From electrocardiographic intervals to prevention of sudden cardiac death
Clinical heterogeneity in Andersen-Tawil syndrome
Sudden cardiac death syndromes: Changing the paradigm of diagnosis from ECG to molecular genetics
Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator.
Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope.